COMMUNIQUÉ DE PRESSE publié le 17/06/2024 à 08:00, il y a 3 mois 2 jours DEFENCE’S CHIEF SCIENTIFIC OFFICER DR. MOUTIH RAFEI DISCUSSES THE ACCUM PLATFORM FOR CANCER TREATMENTS ON MONEY TALK RADIO WITH ELLIS MARTIN Defence Therapeutics Inc.'s Chief Scientific Officer Dr. Moutih Rafei discusses the ACCUM platform for cancer treatments on Money Talk Radio with Ellis Martin Defence Therapeutics Inc. Cancer Treatments ACCUM Platform Dr. Moutih Rafei Money Talk Radio
BRÈVE publiée le 10/06/2024 à 08:05, il y a 3 mois 9 jours Defence Therapeutics participera au congrès annuel 2024 du SNMMI à Toronto Thérapeutique De Défense SNMMI AccuTRIC™ Médecine Nucléaire Imagerie Moléculaire
BRÈVE publiée le 10/06/2024 à 08:05, il y a 3 mois 9 jours Defence Therapeutics to Attend 2024 SNMMI Annual Meeting in Toronto Defence Therapeutics Nuclear Medicine SNMMI AccuTRIC™ Molecular Imaging
COMMUNIQUÉ DE PRESSE publié le 10/06/2024 à 08:00, il y a 3 mois 9 jours DEFENCE TO PARTICIPATE TO 2024 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ANNUAL MEETING IN TORONTO ON JUNE 11, 2024 Defence Therapeutics Inc. to participate in the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto on June 11, 2024, presenting their novel Radio-Immuno-Conjugate (RIC) for cancer treatment Cancer Treatment Defence Therapeutics Inc. Molecular Imaging Society Of Nuclear Medicine Radio-Immuno-Conjugate
BRÈVE publiée le 06/06/2024 à 08:05, il y a 3 mois 13 jours L'étude AccuTOX de Defense Therapeutics publiée dans le Journal of Translational Medicine Immunothérapie Essais Cliniques Thérapeutique De Défense AccuTOX Anti-cancer
BRÈVE publiée le 06/06/2024 à 08:05, il y a 3 mois 13 jours Defence Therapeutics' AccuTOX Study Published in Journal of Translational Medicine Clinical Trials Immunotherapy Defence Therapeutics AccuTOX Anti-cancer
COMMUNIQUÉ DE PRESSE publié le 06/06/2024 à 08:00, il y a 3 mois 13 jours DEFENCE’S ACCUTOX PUBLISHED IN THE PRESTIGIOUS JOURNAL OF TRANSLATIONAL MEDICINE ITS PEER STUDY WITH PRECLINICAL DATA ON ACCUTOX AS AN ANTI-CANCER MOLECULE Defence Therapeutics Inc.'s AccuTOX published in the prestigious Journal of Translational Medicine along with preclinical data on AccuTOX as an anti-cancer molecule. Study highlights AccuTOX's superior therapeutic properties and versatility for different cancer treatments Preclinical Data Defence Therapeutics Inc. AccuTOX Journal Of Translational Medicine Anti-cancer Molecule
BRÈVE publiée le 14/05/2024 à 08:05, il y a 4 mois 5 jours Defence Therapeutics étend son portefeuille de brevets à l'échelle mondiale Thérapeutique De Défense Délivrance De Brevet Innovation Dans Les Soins De Santé Vaccin Immuno-oncologique Système De Délivrance De Médicaments
BRÈVE publiée le 14/05/2024 à 08:05, il y a 4 mois 5 jours Defence Therapeutics Expands Patent Portfolio Globally Defence Therapeutics Patent Issuance Drug Delivery System Innovation In Healthcare Immune-Oncology Vaccine
COMMUNIQUÉ DE PRESSE publié le 14/05/2024 à 08:00, il y a 4 mois 5 jours DEFENCE THERAPEUTICS STRENGTHENS AND EXPANDS GLOBAL PATENT PROTECTION ON KEY TECHNOLOGIES Defence Therapeutics strengthens and expands global patent protection on key technologies, including vaccine enhancer platform and ADC platform technology. The new patents and allowances showcase the company's commitment to innovation in biopharmaceuticals Biopharmaceuticals Defence Therapeutics Patent Protection Vaccine Enhancer ADC Platform Technology
Publié le 19/09/2024 à 17:45, il y a 12 heures 10 minutes Gimv draagt helft van participatie in Infravest over aan WorxInvest (communicatie in toepassing van artikel 7:97 WVV)
Publié le 19/09/2024 à 17:45, il y a 12 heures 10 minutes Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Publié le 19/09/2024 à 17:45, il y a 12 heures 10 minutes Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Publié le 20/09/2024 à 02:00, il y a 3 heures 55 minutes Academy of Math and Science Celebrates Hispanic Heritage Month
Publié le 19/09/2024 à 23:15, il y a 6 heures 40 minutes Cypher Metaverse Inc. Announces Second Closing of Financing
Publié le 19/09/2024 à 23:00, il y a 6 heures 55 minutes WestJet Partners with FLYHT and NOAA to Improve Weather Forecasting in North America
Publié le 19/09/2024 à 23:00, il y a 6 heures 55 minutes Cerrado Files NI 43-101 Preliminary Economic Assessment Technical Report and Mineral Resource Estimate for The Minera Don Nicolas Mine in Santa Cruz, Argentina
Publié le 20/09/2024 à 05:15, il y a 40 minutes Alibaba Cloud Empowers Customers and Partners with its Proven Large Models and High-Performance Infrastructure
Publié le 19/09/2024 à 21:09, il y a 8 heures 45 minutes EQS-Adhoc: Mercedes-Benz Group AG adjusts full-year guidance for the year 2024 based on current market outlook
Publié le 19/09/2024 à 18:44, il y a 11 heures 10 minutes Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 19/09/2024 à 18:03, il y a 11 heures 52 minutes Funding Circle Plc: POS-Transaction in Own Shares
Publié le 19/09/2024 à 17:52, il y a 12 heures 2 minutes PILOT 28 : FIGEAC AÉRO remporte 3 nouveaux contrats sur l'A320 pour 65 millions d'euros